Akshay Vaishnaw
Directeur/Membre du Conseil chez SCHOLAR ROCK HOLDING CORPORATION
Fortune : 3 M $ au 30/04/2024
Postes actifs de Akshay Vaishnaw
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/10/2023 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2006 | 04/01/2022 | |
| President | 04/01/2022 | 02/10/2023 | |
| EDITAS MEDICINE, INC. | Directeur/Membre du Conseil | 28/07/2016 | - |
| Independent Dir/Board Member | 28/07/2016 | - | |
| SCHOLAR ROCK HOLDING CORPORATION | Directeur/Membre du Conseil | 21/05/2019 | - |
| Independent Dir/Board Member | 21/05/2019 | - | |
| The Royal College of Physicians | Corporate Officer/Principal | 07/07/2009 | - |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/05/2019 | - |
Historique de carrière de Akshay Vaishnaw
Anciens postes connus de Akshay Vaishnaw
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VISTERRA INC | Directeur/Membre du Conseil | 01/12/2014 | 01/07/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/1998 | 01/01/2005 |
Formation de Akshay Vaishnaw
| University of London | Doctorate Degree |
| Cardiff University School of Medicine | Doctorate Degree |
| University of Cardiff | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Royaume-Uni | 5 |
Opérationnelle
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 5 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Akshay Vaishnaw
- Expérience